Sridar C[au] - Search Results

Year	Number of Results
2002	1
2004	2
2005	2
2006	2
2008	3
2011	2
2012	3
2013	2
2023	0

1

Anandamide oxidation by wild-type and polymorphically expressed CYP2B6 and CYP2D6.

Sridar C, Snider NT, Hollenberg PF. Sridar C, et al. Drug Metab Dispos. 2011 May;39(5):782-8. doi: 10.1124/dmd.110.036707. Epub 2011 Feb 2. Drug Metab Dispos. 2011. PMID: 21289075 Free PMC article.

2

The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6.

Snider NT, Sikora MJ, Sridar C, Feuerstein TJ, Rae JM, Hollenberg PF. Snider NT, et al. Among authors: sridar c. J Pharmacol Exp Ther. 2008 Nov;327(2):538-45. doi: 10.1124/jpet.108.141796. Epub 2008 Aug 12. J Pharmacol Exp Ther. 2008. PMID: 18698000 Free PMC article.

3

Effect of tamoxifen on the enzymatic activity of human cytochrome CYP2B6.

Sridar C, Kent UM, Notley LM, Gillam EM, Hollenberg PF. Sridar C, et al. J Pharmacol Exp Ther. 2002 Jun;301(3):945-52. doi: 10.1124/jpet.301.3.945. J Pharmacol Exp Ther. 2002. PMID: 12023523

4

Quantitation of UGT1A1 in human liver microsomes using stable isotope-labelled peptides and mass spectrometry based proteomic approaches.

Sridar C, Hanna I, Hollenberg PF. Sridar C, et al. Xenobiotica. 2013 Apr;43(4):336-45. doi: 10.3109/00498254.2012.719089. Epub 2012 Sep 3. Xenobiotica. 2013. PMID: 22943130

5

The inactivation of human CYP2E1 by phenethyl isothiocyanate, a naturally occurring chemopreventive agent, and its oxidative bioactivation.

Yoshigae Y, Sridar C, Kent UM, Hollenberg PF. Yoshigae Y, et al. Among authors: sridar c. Drug Metab Dispos. 2013 Apr;41(4):858-69. doi: 10.1124/dmd.112.050609. Epub 2013 Jan 31. Drug Metab Dispos. 2013. PMID: 23371965 Free PMC article.

6

Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases.

Sridar C, Goosen TC, Kent UM, Williams JA, Hollenberg PF. Sridar C, et al. Drug Metab Dispos. 2004 Jun;32(6):587-94. doi: 10.1124/dmd.32.6.587. Drug Metab Dispos. 2004. PMID: 15155549

7

Synthesis of substituted phenyl diaziridines and characterization as mechanism-based inactivators of human cytochrome P450 2B6.

Sridar C, Kobayashi Y, Brevig H, Kent UM, Puppali SG, Rimoldi JM, Hollenberg PF. Sridar C, et al. Drug Metab Dispos. 2006 Nov;34(11):1849-55. doi: 10.1124/dmd.106.010082. Epub 2006 Aug 1. Drug Metab Dispos. 2006. PMID: 16882766

8

Inhibition of bupropion metabolism by selegiline: mechanism-based inactivation of human CYP2B6 and characterization of glutathione and peptide adducts.

Sridar C, Kenaan C, Hollenberg PF. Sridar C, et al. Drug Metab Dispos. 2012 Dec;40(12):2256-66. doi: 10.1124/dmd.112.046979. Epub 2012 Aug 30. Drug Metab Dispos. 2012. PMID: 22936314 Free PMC article.

9

Bioactivation of the cancer chemopreventive agent tamoxifen to quinone methides by cytochrome P4502B6 and identification of the modified residue on the apoprotein.

Sridar C, D'Agostino J, Hollenberg PF. Sridar C, et al. Drug Metab Dispos. 2012 Dec;40(12):2280-8. doi: 10.1124/dmd.112.047266. Epub 2012 Aug 31. Drug Metab Dispos. 2012. PMID: 22942317 Free PMC article.

10

Polymorphic variants of cytochrome P450 2B6 (CYP2B6.4-CYP2B6.9) exhibit altered rates of metabolism for bupropion and efavirenz: a charge-reversal mutation in the K139E variant (CYP2B6.8) impairs formation of a functional cytochrome p450-reductase complex.

Zhang H, Sridar C, Kenaan C, Amunugama H, Ballou DP, Hollenberg PF. Zhang H, et al. Among authors: sridar c. J Pharmacol Exp Ther. 2011 Sep;338(3):803-9. doi: 10.1124/jpet.111.183111. Epub 2011 Jun 9. J Pharmacol Exp Ther. 2011. PMID: 21659470 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results